PIKEVILLE MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1M
- Transactions
- 272
- Companies
- 40
- Average per transaction
- $3,831
Who reported the payments
| Merck | $284,963 |
| Amgen | $218,956 |
| Stryker | $132,580 |
| GSK | $103,962 |
| Radius Health, Inc. | $59,465 |
| Stemline Therapeutics Inc. | $56,647 |
| AbbVie | $27,922 |
| Jazz Pharmaceuticals Inc. | $19,346 |
| Ipsen Bioscience Inc. | $11,920 |
| Pfizer | $10,400 |
| Janssen Research & Development, LLC | $10,090 |
| Linvatec Corporation | $9,750 |
| Merge Healthcare Incorporated | $8,568 |
| Genentech, Inc. | $8,500 |
| E.r. Squibb & Sons, L.L.C. | $6,550 |
| Eli Lilly | $6,452 |
| CSL Behring | $6,000 |
| Hoffmann-la Roche Limited | $6,000 |
| Concordance Healthcare Solutions, LLC | $5,658 |
| Chiesi USA, Inc. | $4,000 |
| Bard Peripheral Vascular, Inc. | $3,800 |
| Medline Industries LP | $3,717 |
| Boston Scientific | $3,000 |
| Portola Pharmaceuticals, LLC | $3,000 |
| Johnson & Johnson | $2,934 |
| Fisher Scientific Company L.L.C. | $2,597 |
| Edwards Lifesciences | $2,000 |
| AstraZeneca | $2,000 |
| Alnylam Pharmaceuticals Inc. | $2,000 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $2,000 |
| Gilead | $2,000 |
| BD | $2,000 |
| Boehringer Ingelheim | $2,000 |
| Shionogi Inc | $2,000 |
| Abbott | $1,500 |
| Daiichi Sankyo Inc. | $1,432 |
| Virtual Imaging, Inc. | $1,400 |
| Novartis | $1,000 |
| Insmed, Inc. | $1,000 |
| Cardiva Medical, Inc. | $1,000 |